Clinical Trials Logo

Clinical Trial Summary

Pilot study of bioabsorbable implant and delivery device for correction of septal deviation.


Clinical Trial Description

To evaluate the safety and effectiveness of the Spirair Implant as a primary treatment for correction of cartilaginous nasal septal deviation. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06163404
Study type Interventional
Source Spirair, Inc
Contact Margo Snyder
Phone 615-483-7438
Email margo@spirair.com
Status Recruiting
Phase N/A
Start date November 1, 2023
Completion date July 2025

See also
  Status Clinical Trial Phase
Active, not recruiting NCT01960816 - InFlux System for Nasal Breathing Improvement N/A
Enrolling by invitation NCT03233373 - Thermal Imaging as a Potential Diagnostic Tool of Nasal Airflow
Recruiting NCT05527652 - Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia N/A
Completed NCT05747014 - Novapak Prospective Observational Clinical Trial
Active, not recruiting NCT04549545 - Vivaer® Procedure for Treatment of Nasal Airway Obstruction Study N/A
Active, not recruiting NCT05446714 - Evaluation of the Effect of Three Types of Rapid Maxillary Expanders (Conventional, Hybrid and MSE) N/A